Can IVF be done in Thailand for repeated implantation failure? Determine the cause first, then decide the plan

AI Summary

Last week, a 34-year-old patient sent a message: She had already undergone 3 transfers of high-quality embryos in China, all of which failed to implant. Each time, her endometrial thickness and hormone levels were normal, but the embryo just "wouldn't take." She asked, "In my situation, can IVF in Thailand be successful?" This is not an isolated case. Repeated implantation failure (RIF) accounts for about 10%-15% of cases in assisted reproduction. Due to the high prevalence of third-generation IVF and mature personalized transfer protocols, Thailand has become a consideration for many RIF patients. However, the answer is not a simple "yes" or "no." The key lies in whether the cause of failure is clear and whether the Thai protocol can specifically address it.

Can IVF be done in Thailand for repeated implantation failure?

Yes, but with prerequisites. Thai IVF is not a "universal remedy" for RIF, but rather offers new technical pathways for repeated failure caused by specific reasons. If the cause of failure is embryonic chromosomal aneuploidy (especially in older women), displaced endometrial receptivity, chronic endometritis, or mild immune abnormalities, Thailand's PGT-A, ERA, EMMA/ALICE, and personalized transfer protocols can indeed lead to improvements. However, if the cause is complete follicle depletion, severe uterine abnormalities, or uncontrolled autoimmune diseases, Thai IVF is unlikely to overcome these issues.

Common causes of repeated implantation failure

The essence of RIF is a failure in the "dialogue" between the embryo and the endometrium. Based on clinical data, the causes can be categorized as follows:

• Embryo factors (accounting for about 40%-50%): Chromosomal aneuploidy is the main cause, especially in women aged ≥35, where the incidence increases significantly. PGT-A can screen for euploid embryos, reducing implantation failure due to embryonic abnormalities.
• Abnormal endometrial receptivity (accounting for about 25%-30%): Displacement of the endometrial "implantation window" is a common issue. ERA testing can precisely determine the optimal time for transfer. In some patients, the implantation window is displaced by more than 24 hours, making implantation impossible with conventional transfer timing.
• Chronic endometritis (accounting for about 10%-15%): Asymptomatic chronic inflammation can interfere with implantation. EMMA/ALICE testing can identify microbial dysbiosis or specific pathogens, and targeted antibiotic treatment can improve outcomes.
• Immune factors (accounting for about 5%-10%): These include abnormal NK cell activity, positive antiphospholipid antibodies, and thyroid autoantibodies. Some Thai clinics incorporate immune modulation protocols.
• Endocrine and anatomical factors: Uncontrolled thyroid dysfunction, hyperprolactinemia, intrauterine adhesions, polyps, or fibroids.

Reproductive specialists' evaluation logic for RIF patients considering Thailand

In my 10 years of experience, we do not simply advise RIF patients to "try Thailand." Instead, we first complete a systematic evaluation. Doctors typically focus on the following core questions:

• Were the previously transferred embryos euploid? If PGT was not performed, embryonic factors cannot be ruled out.
• Has endometrial receptivity been tested? Normal endometrial thickness on ultrasound does not mean the implantation window is normal.
• Has a hysteroscopy been performed? About 30% of RIF patients have minor intrauterine pathologies.
• Have immune and coagulation functions been screened? Especially for patients with a history of repeated implantation failure and miscarriage.
• Does age and ovarian reserve allow for another egg retrieval? If AMH is <0.5 ng/mL, the number of eggs retrieved will be limited, requiring careful decision-making.

Only after answering these questions can we determine whether a Thai protocol can truly offer new value.

Main differences between Thailand and China in RIF management

However, it should be noted that the quality of clinics in Thailand varies greatly. Not all clinics have the same testing capabilities and laboratory standards. When choosing, it is necessary to verify their embryology lab qualifications, PGT technology platform, and clinical data.

Three details most easily overlooked by RIF patients

• Endometrial microbiome status: Many patients only focus on endometrial thickness and pattern, ignoring the balance of the microbiome. Chronic endometritis is often asymptomatic but can significantly reduce implantation rates. EMMA/ALICE testing should be a routine investigation for RIF.
• Re-evaluation of male factors: If only a routine semen analysis was done previously, it is recommended to add sperm DNA fragmentation index (DFI) and chromosomal karyotyping. When DFI is ≥30%, even if blastocysts form, their implantation potential decreases.
• "True quality" of transferred embryos: Blastocysts with high morphological grading are not necessarily chromosomally normal. PGT-A can reveal that about 30%-50% of morphologically good-quality blastocysts are actually aneuploid.

Common pitfalls when going to Thailand for IVF

• Going to Thailand without prior examinations: Some patients think Thailand can solve everything in one stop. But without basic examinations in China (AMH, hysteroscopy, immune screening, etc.), they may find upon arrival that they are not suitable for egg retrieval or transfer, resulting in wasted time and money.
• Blindly choosing a clinic: There are over 100 IVF clinics in Thailand, with huge differences in lab standards, doctor experience, and PGT technology platforms. It is advisable to choose institutions with >500 cycles per year, an independent embryology lab, and publicly available clinical data.
• Ignoring document preparation: IVF in Thailand requires a notarized translation of the marriage certificate, a passport (valid for ≥6 months), a visa, etc. Some patients delay their cycles due to document issues.
• Misinterpreting success rates: The "success rates" published by Thai clinics are usually based on specific populations (e.g., age <35, non-RIF patients). The actual implantation rate for RIF patients can be 10%-20% lower, so expectations should be realistic.

Actual process and timeline for RIF patients going to Thailand for IVF

Phase 1: Systematic evaluation in China (recommended 1-2 months in advance)

• Female: AMH, FSH, LH, antral follicle count, hysteroscopy + endometrial biopsy, chromosomal karyotype, thyroid function, full immune panel (NK cells, antiphospholipid antibodies, thyroid antibodies, etc.)
• Male: Semen analysis + sperm DNA fragmentation index, chromosomal karyotype
• Both: Infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis, etc.)

Phase 2: Choose a clinic and register (1 month in advance)

• Submit all examination reports for pre-review by the Thai doctor
• Confirm whether it is suitable to start the cycle
• Prepare documents: Passport (valid for ≥6 months), notarized translation of marriage certificate, visa

Phase 3: Travel to Thailand for ovarian stimulation and egg retrieval (about 12-14 days)

• Arrive in Thailand on day 2-3 of menstruation to start ovarian stimulation
• Average stimulation duration is 10-12 days
• Egg retrieval surgery (under intravenous anesthesia, about 15-20 minutes)

Phase 4: Embryo culture + PGT-A screening (about 1-2 months)

• Blastocyst culture for 5-6 days
• Trophectoderm biopsy + PGT-A (NGS platform, results in about 3-4 weeks)
• If ERA/EMMA/ALICE is also being done, endometrial sampling is needed in the cycle before transfer

Phase 5: Frozen embryo transfer (about 12-14 days)

• Determine transfer timing based on ERA results
• Prepare the endometrium using hormone replacement or natural cycle
• Luteal phase support for 12-14 days after transfer
• Check blood HCG on day 12-14 to confirm pregnancy

Frequently asked questions from RIF patients

Can I still go to Thailand for IVF with low AMH?

When AMH is <0.5 ng/mL, the number of eggs retrieved is usually ≤3, and the probability of forming a euploid blastocyst is low. However, if age is ≤38, it is still possible to obtain 1-2 euploid embryos. The advantage of the Thai protocol is that PGT-A can screen the limited number of euploid embryos, avoiding blind transfers. However, be mentally prepared for few eggs and the possibility of having no embryo to transfer.

Is there still hope for older (≥40) patients with repeated implantation failure going to Thailand?

For RIF patients over 40, the embryonic aneuploidy rate can reach 60%-80%. PGT-A can screen for chromosomally normal embryos, but the prerequisite is obtaining a sufficient number of blastocysts. If AMH is ≥1.0 ng/mL and the antral follicle count is ≥5, there is still hope. If ovarian reserve is nearly depleted, it is recommended to first undergo 1-2 cycles of follicle recruitment assessment before deciding.

How long does IVF in Thailand take?

From the initial evaluation to the completion of the transfer, it usually takes 3-4 months. This includes about 2 weeks in Thailand for ovarian stimulation and egg retrieval, about 1-2 months for embryo culture and PGT screening (results can be waited for in China), and another 2-week trip to Thailand for the transfer cycle. If ERA/EMMA/ALICE is also performed, an additional cycle (about 1 month) is needed.

What is the approximate cost of IVF in Thailand?

Ovarian stimulation + egg retrieval + PGT-A + embryo culture costs about 80,000-120,000 RMB. A frozen embryo transfer cycle costs about 30,000-50,000 RMB. Total medical expenses are about 120,000-180,000 RMB. This does not include transportation, accommodation, and living expenses. If ERA/EMMA/ALICE testing is needed, an additional 15,000-25,000 RMB is required.

Observations from 10 years of practice: Which RIF patients benefit more from the Thai protocol

Based on actual cases, the following three types of RIF patients benefit more significantly from the Thai protocol:

• Clearly defined embryonic factors: Previous transferred embryos were not tested with PGT, or were confirmed to be aneuploid. Thai PGT-A can screen for euploid embryos, significantly improving the success rate per single transfer.
• Displaced endometrial receptivity: ERA testing reveals an implantation window displacement of more than 12 hours. Adjusting the transfer timing can increase the implantation rate from about 15% to around 45%.
• Chronic endometritis: EMMA/ALICE detects pathogens or microbial dysbiosis. After targeted antibiotic treatment, the success rate of subsequent transfers can increase by 2-3 times.

However, blindly going to Thailand is not recommended in the following situations: nearly exhausted ovarian function (AMH <0.3 ng/mL), severe uterine abnormalities (e.g., unicornuate uterus, uncorrected septate uterus), uncontrolled autoimmune diseases (e.g., active systemic lupus erythematosus), or a previous confirmed lack of response to the Thai protocol (e.g., previous failed transfer in Thailand with unknown cause).